Aytu has acquired 3 companies.
Aytu’s largest acquisition to date was in 2019, when it acquired Innovus Pharmaceuticals for $8M. Aytu has acquired in 2 different US states. The Company’s most targeted sectors include medical products (67%) and life science (34%).
Denver Corporate Center III 7900 East Union Avenue Suite 920,
Denver, Colorado
80237
United States,
(720) 437-6580
www.aytubio.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2019-09-12 |
Innovus Pharmaceuticals, Inc. · Medical Products
San Diego, California · www.innovuspharma.com Innovus Pharmaceuticals, Inc. is a pharmaceutical company. The company produces consumer products for men's and women's health and vitality. The company generates revenues from its lead products Zestra(R) for female arousal and EjectDelay(R) for premature ejaculation and has a total of five marketed products in this space. Innovus Pharmaceuticals was founded in 2008 and is based in San Diego, California.
|
8
0.3x REVENUE |
Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
